Published in Medical Letter on the CDC and FDA, April 1st, 2007
"The Company is looking forward to several key regulatory milestones, including the regulatory opinion from Europe on the Genasense marketing application for patients with advanced melanoma", said Dr. Raymond P. Warrell, Jr.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.